John McKivison sued Bayer because he believes he developed cancer after using Roundup on his property for two decades,
Unveiling the controversy: a deep dive into the legal, scientific, and humanitarian debate over glyphosate's future
A “significant further decline” of glyphosate sales could push Bayer towards a breakup of its agriculture business.
Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015.
Monsanto owner, Bayer AG, is contemplating pulling the popular herbicide from the residential market as it struggles to cement a strategy to limit ongoing litigation.
Monsanto’s campaign to target journalists and activists was ranked the second most neglected story of 2020 according to the nonprofit media watchdog.
“Removing glyphosate from residential use would be a step in the right direction.”
“Our rationale is based on the precautionary principle in the face of environmental risks as well as the right of the Mexican government to take action in favor of the public good.”
Bayer will have to pay between "$8.8 billion to $9.6 billion to resolve current Roundup lawsuits."
“Even as we celebrate and congratulate those who made this day possible, millions of people are being exposed to glyphosate.”